Phreesia (PHR) reported $102.12 million in income for the quarter ended July 2024, representing a year-over-year improve of 19%. EPS of -$0.31 for a similar interval compares to -$0.68 a yr in the past.
The reported income represents a shock of +0.35% over the Zacks Consensus Estimate of $101.76 million. With the consensus EPS estimate being -$0.37, the EPS shock was +16.22%.
Whereas buyers intently watch year-over-year modifications in headline numbers — income and earnings — and the way they examine to Wall Road expectations to find out their subsequent plan of action, some key metrics all the time present a greater perception into an organization’s underlying efficiency.
Since these metrics play an important position in driving the top- and bottom-line numbers, evaluating them with the year-ago numbers and what analysts estimated about them helps buyers higher venture a inventory’s worth efficiency.
Right here is how Phreesia carried out within the simply reported quarter by way of the metrics most generally monitored and projected by Wall Road analysts:
-
Common healthcare companies Purchasers
: 4,169 in comparison with the 4,159 common estimate primarily based on three analysts.
-
Affected person cost quantity
: $1.09 billion in comparison with the $1.13 billion common estimate primarily based on three analysts.
-
Common income per healthcare companies shopper
: $17.73 million versus the two-analyst common estimate of $18.20 million.
-
Revenus- Subscription and associated companies
: $48.61 million in comparison with the $47.93 million common estimate primarily based on six analysts. The reported quantity represents a change of +23.7% yr over yr.
-
Revenus- Community options
: $28.20 million versus the six-analyst common estimate of $28.06 million. The reported quantity represents a year-over-year change of +23.2%.
-
Revenus- Cost processing charges
: $25.30 million in comparison with the $25.76 million common estimate primarily based on six analysts. The reported quantity represents a change of +7.1% yr over yr.
View all Key Company Metrics for Phreesia here>>>
Shares of Phreesia have returned +4.5% over the previous month versus the Zacks S&P 500 composite’s +3.6% change. The inventory at present has a Zacks Rank #2 (Purchase), indicating that it may outperform the broader market within the close to time period.
5 Shares Set to Double
Every was handpicked by a Zacks knowledgeable because the #1 favourite inventory to achieve +100% or extra in 2024. Whereas not all picks could be winners, earlier suggestions have soared +143.0%, +175.9%, +498.3% and +673.0%.
Many of the shares on this report are flying beneath Wall Road radar, which supplies an excellent alternative to get in on the bottom flooring.
Today, See These 5 Potential Home Runs >>
Phreesia, Inc. (PHR) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially mirror these of Nasdaq, Inc.
